2022. 7. 23. · , Medytox, Merz Pharma, Nestlé Pores and skin Well being, Galderma Laboratories, L Daewoong then released its botulinum toxin named Nabota in the country in 2014 imports of its A Total of Nine FDA Therapeutic Approvals for BOTOX Have Helped Drive the Growth of the Therapeutic Neuromodulator Sales Sources: AGN, analysts’ reports, EvaluatePharma,. Out of this foursome, though, Jeuveau is the first toxin to be formulated with the same 900 kDa molecular weight as Botox. Xeomin, on the other hand, has a 150 kDa molecular weight, and Dysport comes in a range of molecular sizes.. Botox®, Jeuveau and Dysport are three neuromodulators that work to reverse the visible signs of aging by relaxing the muscles beneath the skins surface. Botox®, Jeuveau and Dysport are three of the four FDA injectables that can effectively treat the formation of wrinkles and deeper lines. Wrinkles form over time as a result of repeated muscle. Jeuveau Reston. In February 2019, the U.S. Food and Drug Administration approved a new neuromodulator called Jeuveau.. Botox has been the mainstay of antiaging injectables for so long that it’s easy to forget that there are other neurotoxin options. While Dysport and Xeomin have offered some competition, Botox has remained the gold standard for over 20 years. Jeuveau is the first neurotoxin FDA-approved for aesthetic usage in close to a decade. A dermatologist shares how its similar and different to other neurotoxins on the market, including Botox.